Literature DB >> 32866441

Prognostic Implications of Significant Isolated Tricuspid Regurgitation in Patients With Atrial Fibrillation Without Left-Sided Heart Disease or Pulmonary Hypertension.

Marlieke F Dietz1, Laurien Goedemans1, N Mai Vo1, Edgard A Prihadi2, Pieter van der Bijl1, Bernard J Gersh3, Nina Ajmone Marsan1, Victoria Delgado1, Jeroen J Bax4.   

Abstract

The prognostic impact of isolated tricuspid regurgitation (TR) in patients with atrial fibrillation (AF) has not been investigated. The purpose of this study was to investigate the prognostic implications of significant isolated TR in AF patients without left-sided heart disease, pulmonary hypertension, or primary structural abnormalities of the tricuspid valve. A total of 63 AF patients with moderate and severe TR were matched for age and gender to 116 AF patients without significant TR. Patients were followed for the occurrence of all-cause mortality, hospitalization for heart failure and stroke. Patients with significant isolated TR (mean age 71 ± 8 years, 57% men) more often had paroxysmal AF as compared with patients without TR (mean age 71 ± 7 years, 60% men) (60% vs 43%, p = 0.028). In addition, right atrial size and tricuspid annular diameter were significantly larger in patients with significant isolated TR compared with their counterparts. During follow-up (median 62 [34 to 95] months), 53 events for the combined endpoint occurred. One- and 5-year event-free survival rates for patients with significant isolated TR were 76% and 56%, compared with 92% and 85% for patients without significant TR, respectively (Log rank Chi-Square p <0.001). The presence of significant isolated TR was independently associated with the combined endpoint (hazard ratio, 2.853; 95% confidence interval, 1.458 to 5.584; p = 0.002). In conclusion, in the absence of left-sided heart disease and pulmonary hypertension, significant isolated TR is independently associated with worse event-free survival in patients with AF.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32866441     DOI: 10.1016/j.amjcard.2020.08.034

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Genetically Predicted Atrial Fibrillation and Valvular Heart Disease: A Two-Sample Mendelian Randomization Study.

Authors:  Jie Gao; Yulin Bai; Hongwen Ji
Journal:  Front Cardiovasc Med       Date:  2022-03-28

2.  Higher Hospitalization Rate and Impaired Quality of Life in the Presence of Severe Tricuspid Regurgitation in Patients With Newly Diagnosed Atrial Fibrillation: Is the Risk Real?

Authors:  Sanghamitra Mohanty; Andrea Natale
Journal:  J Am Heart Assoc       Date:  2022-04-06       Impact factor: 6.106

3.  Prognostic Implications of Biventricular Global Longitudinal Strain in Patients With Severe Isolated Tricuspid Regurgitation.

Authors:  Dae-Young Kim; Jiwon Seo; Iksung Cho; Seung Hyun Lee; Sak Lee; Geu-Ru Hong; Jong-Won Ha; Chi Young Shim
Journal:  Front Cardiovasc Med       Date:  2022-08-03

4.  Edge-to-Edge Repair for Tricuspid Valve Regurgitation. Preliminary Echo-Data and Clinical Implications from the Tricuspid Regurgitation IMAging (TRIMA) Study.

Authors:  Myriam Carpenito; Valeria Cammalleri; Luka Vitez; Aurelio De Filippis; Edoardo Nobile; Maria Caterina Bono; Simona Mega; Matjaz Bunc; Francesco Grigioni; Gian Paolo Ussia
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.